Question 1

What are the potential benefits of participating in this trial compared to my current treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder clinical trial (NCT02161718). Contact the study team or your healthcare provider for specific answers.

Question 2

How will I be monitored during the study, and what tests will I need to undergo?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder clinical trial (NCT02161718). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the possible side effects of ALKS 3831?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder clinical trial (NCT02161718). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to visit the study site, and what will those visits involve?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder clinical trial (NCT02161718). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience worsening symptoms during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder clinical trial (NCT02161718). Contact the study team or your healthcare provider for specific answers.

Question 6

Can you explain the difference between the active treatment and the placebo?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder clinical trial (NCT02161718). Contact the study team or your healthcare provider for specific answers.

What this study is about